Cargando…
Signaling Pathways of ESE-16, an Antimitotic and Anticarbonic Anhydrase Estradiol Analog, in Breast Cancer Cells
The aim of this study was to characterize the in vitro action of 2-ethyl-3-O-sulphamoyl-estra-1,3,5(10)16-tetraene (ESE-16) on non-tumorigenic MCF-12A, tumorigenic MCF-7 and metastatic MDA-MB-231 breast cancer cells. ESE-16 is able to inhibit the activity of a carbonic anhydrase II and a mimic of ca...
Autores principales: | Stander, Barend Andre, Joubert, Fourie, Tu, Chingkuang, Sippel, Katherine H., McKenna, Robert, Joubert, Annie Margaretha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561402/ https://www.ncbi.nlm.nih.gov/pubmed/23382857 http://dx.doi.org/10.1371/journal.pone.0053853 |
Ejemplares similares
-
Correction: Signaling Pathways of ESE-16, an Antimitotic and Anticarbonic Anhydrase Estradiol Analog, in Breast Cancer Cells
por: Stander, Barend Andre, et al.
Publicado: (2013) -
In Vitro Evaluation of ESE-15-ol, an Estradiol Analogue with Nanomolar Antimitotic and Carbonic Anhydrase Inhibitory Activity
por: Stander, Barend Andre, et al.
Publicado: (2012) -
Induction of the intrinsic apoptotic pathway via a new antimitotic agent in an esophageal carcinoma cell line
por: Wolmarans, Elize, et al.
Publicado: (2014) -
Novel estradiol analogue induces apoptosis and autophagy in esophageal carcinoma cells
por: Wolmarans, Elize, et al.
Publicado: (2014) -
Antimitotic drugs in the treatment of cancer
por: van Vuuren, Rustelle Janse, et al.
Publicado: (2015)